Publications

2022

Marron TU, Fiel MI, Hamon P, Fiaschi N, Kim E, Ward SC, et al. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022;7(3):219-229.
Boyraz B, Watkins JC, Soubeyran I, Bonhomme B, Croce S, Oliva E, et al. Cystic Granulosa Cell Tumors of the Ovary: An Analysis of 80 Cases of an Often Diagnostically Challenging Entity. Arch Pathol Lab Med. 2022;146(12):1450-1459.
Young A, Bu W, Jiang W, Ku A, Kapali J, Dhamne S, et al. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prev Res (Phila). 2022;15(1):3-10.
Solomon JP, Yang S-, Choudhury NJ, Ptashkin RN, Eslamdoost N, Falcon CJ, et al. Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors. Clin Cancer Res. 2022;28(21):4649-4659.
Smithgall MC, Murphy EA, Rand S, Sukhu A, Singh S, Schatz-Siemers N, et al. Placental pathology, neonatal birth weight, and Apgar score in acute and distant SARS-CoV-2 infection. J Clin Transl Res. 2022;8(5):351-359.
Mossanen M, Nassar AH, Stokes SM, Martinez-Chanza N, Kumar V, Nuzzo PV, et al. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes. Clin Genitourin Cancer. 2022;20(6):568-574.
Sattler SS, Magro CM, Shapiro L, Merves JF, Levy R, Veenstra J, et al. Gastrointestinal Kohlmeier-Degos disease: a narrative review. Orphanet J Rare Dis. 2022;17(1):172.
Dallimore CA, Quelle M, Désir LL, Sham S, Harshan M, Wahl SJ, et al. Calcifying Pseudoneoplasm of the Neuraxis in the Posterior Fossa: A Case Report and Literature Review. Cureus. 2022;14(1):e21562.
Cambuli F, Foletto V, Alaimo A, De Felice D, Gandolfi F, Palumbieri MD, et al. Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence. EMBO Rep. 2022;23(5):e54049.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700